Penumbra, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
PEN New York 3841 www.penumbrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Penumbra, Inc.

First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke - Jul 7th, 2026 7:00 am
GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT - Jul 6th, 2026 6:00 am
GMED vs. PEN: Which Stock Should Value Investors Buy Now? - Jun 22nd, 2026 9:40 am
Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain? - Jun 18th, 2026 10:47 am
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? - Jun 18th, 2026 4:36 am
Penumbra wins CE mark for Thunderbolt clot removal tech - Jun 18th, 2026 4:00 am
Medtech M&A maintains momentum following decade-high 2025: PwC - Jun 17th, 2026 5:00 am
Penumbra’s Thunderbolt approval poised to accelerate neuro thrombectomy innovation - Jun 16th, 2026 10:27 am
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT - Jun 15th, 2026 7:00 am
Boston Scientific Eyes Neurovascular Growth With Penumbra Thunderbolt Clearance - Jun 13th, 2026 1:17 am
FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke - Jun 12th, 2026 9:34 am
Penumbra's Thunderbolt Device Offers Revenue Upside Not Reflected in Estimates, RBC Says - Jun 12th, 2026 8:52 am
Penumbra’s FDA nod for clot removal tech a win for Boston Scientific - Jun 12th, 2026 5:22 am
Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke - Jun 11th, 2026 2:05 pm
GMED or PEN: Which Is the Better Value Stock Right Now? - Jun 5th, 2026 9:40 am
Why Is Penumbra (PEN) Down 1.2% Since Last Earnings Report? - Jun 5th, 2026 9:30 am
Here’s What Supports Penumbra’s (PEN) Revenue Growth and Margin Expansion - Jun 5th, 2026 7:14 am
Boston Scientific Bets on Growth Through Strategic M&A Deals - May 18th, 2026 12:15 pm
Champlain Sells Out of Freshpet Position, Dumps $125 Million in Stock - May 14th, 2026 11:00 pm
Assessing Penumbra (PEN) Valuation As Growth Expectations Meet A Premium P/E Multiple - May 7th, 2026 1:08 am